
High blood xylitol linked to 57% higher MACE risk in observational cohorts (ESC 2026)
A study presented at ESC Congress 2026 analyzed 17,710 participants from CLSA and EPIC-Norfolk. Highest-quartile xylitol levels were associated with 57% higher MACE risk over six years in CLSA and 18% higher over 30 years in EPIC-Norfolk, with a dose-response pattern. It is observational and cannot show xylitol causes events.




